Presentation Title

Use of Cancer Treatment Plans in Georgia: Results from 2012 and 2017 BRFSS

Location

Jiann-Ping Hsu College of Public Health (JPHCOPH)

Session Format

Poster Presentation

Co-Presenters and Faculty Mentors or Advisors

Dr. Yelena Tarasenko, Faculty Advisor

Abstract

Background: To inform development of interventions on follow-up care and resource allocation for cancer survivors in Georgia, in collaboration with the GDPH, we assessed progress in use of cancer treatment plans, as recommended by the ASCO.

Methods: This observational study was based on cross-sectional data from the 2012 and 2017 GA BRFSS. All analyses employed sampling weights to adjust to the selection probabilities and nonresponse. Changes in receipt of a written cancer treatment plan were examined using unadjusted and adjusted binary logistic regression analyses.

Results: The average adult cancer survivor was aged 62.95 years in 2017 compared to 60.83 in 2012 (p < 0.001). In 2017, 52.58% of adult cancer survivors received a cancer treatment summary compared to 40.57% in 2012 (p = 0.022). Those who received treatment summaries had a higher age of cancer diagnosis (p = 0.035) and received more instructions for routine check-ups compared to those who did not (p < 0.001). Differences in receipt of treatment summaries were not observed by sex, race or ethnicity, education, BMI, or income levels.

Conclusions: Increase in use of cancer treatment plans is an important step toward improving quality of follow-up care and health outcomes of cancer survivors in Georgia

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Presentation Type and Release Option

Presentation (Open Access)

This document is currently not available here.

Share

COinS
 

Use of Cancer Treatment Plans in Georgia: Results from 2012 and 2017 BRFSS

Jiann-Ping Hsu College of Public Health (JPHCOPH)

Background: To inform development of interventions on follow-up care and resource allocation for cancer survivors in Georgia, in collaboration with the GDPH, we assessed progress in use of cancer treatment plans, as recommended by the ASCO.

Methods: This observational study was based on cross-sectional data from the 2012 and 2017 GA BRFSS. All analyses employed sampling weights to adjust to the selection probabilities and nonresponse. Changes in receipt of a written cancer treatment plan were examined using unadjusted and adjusted binary logistic regression analyses.

Results: The average adult cancer survivor was aged 62.95 years in 2017 compared to 60.83 in 2012 (p < 0.001). In 2017, 52.58% of adult cancer survivors received a cancer treatment summary compared to 40.57% in 2012 (p = 0.022). Those who received treatment summaries had a higher age of cancer diagnosis (p = 0.035) and received more instructions for routine check-ups compared to those who did not (p < 0.001). Differences in receipt of treatment summaries were not observed by sex, race or ethnicity, education, BMI, or income levels.

Conclusions: Increase in use of cancer treatment plans is an important step toward improving quality of follow-up care and health outcomes of cancer survivors in Georgia